Homodimerization of erythropoietin receptor by a bivalent monoclonal antibody triggers cell proliferation and differentiation of erythroid precursors

Blood

Volumn 89, Issue 2, 1997, Pages 473-482

  Schneider, Helmut ^a   Chaovapong, Warak ^b   Matthews, David J ^b   Karkaria, Cyrus ^b   Cass, Robert T ^b   Zhan, Hangjun ^b   Boyle, Mark ^b   Lorenzini, Tony ^b   Elliott, Steve G ^b   Giebel, Lutz B ^b  

^a Arris Pharmaceutical Corporation   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY;

ANIMAL CELL; ARTICLE; BURST FORMING UNIT E; CELL DIFFERENTIATION; CELL PROLIFERATION; DIMERIZATION; ERYTHROID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

EID: 0031033923     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.2.473     Document Type: Article

References (44)

1. Krantz SB: Erythropoietin. Blood 77:419, 1991
2. Koury MJ, Bondurant MC: Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378, 1990
3. Zhuang H, Niu Z, He TC, Patel SV, Wojchowski DM: Erythropoietin-dependent inhibition of apoptosis is supported by carboxyltruncated receptor forms and blocked by dominant-negative forms of Jak2. J Biol Chem 270:14500, 1995
4. Youssoufian H, Longmore G, Neumann D, Yoshimura A, Lodish HF: Structure, function, and activation of the erythropoietin receptor. Blood 81:2223, 1993
5. Wu H, Liu X, Jaenisch R, Lodish HF: Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59, 1995
6. Bazan JF: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934, 1990
7. Alexander WS, Metcalf D, Dunn AR: Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J 14:5569, 1995
8. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Morlarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI: Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263, 1995
9. Heldin C-H: Dimerization of cell surface receptors in signal transduction. Cell 80:213, 1995
10. Livnah O, Stura EA, Johnson DL, Middleton SA, Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe LK, Wilson IA: Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 A. Science 273:464, 1996
11. Philo JS, Aoki KH, Arakawa T, Narhi LO, Wen J: Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: One high-affinity and one low-affinity interaction. Biochemistry 35:1681, 1996
12. Longmore GD, Lodish HF: An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: A cytokine receptor superfamily oncogene. Cell 67:1089, 1991
13. Yoshimura A, Longmore G, Lodish HF: Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 348: 647, 1990
14. Watowich SS, Yoshimura A, Longmore GD, Hilton DJ, Yoshimura Y, Lodish HF: Homodimerization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci USA 89:2140, 1992
15. Watowich SS, Hilton DJ, Lodish HF: Activation and inhibition of erythropoietin receptor function: Role of receptor dimerization. Mol Cell Biol 14:3535, 1994
16. Longmore GD, Pharr PN, Lodish HF: A constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multipotent, committed nonerythroid and erythroid progenitor cells. Mol Cell Biol 14:2266, 1994
17. Pharr PN, Hankins D, Hofbauer A, Lodish HF, Longmore GD: Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth. Proc Natl Acad Sci USA 90:938, 1993
18. Barber DL, DeMartino JC, Showers MO, D'Andrea AD: A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation. Mol Cell Biol 14:2257, 1994
19. Miura O, Ihle JN: Dimer-and oligomerization of the erythropoietin receptor by disulfide bond formation and significance of the region near the WSXWS motif in intracellular transport. Arch Biochem Biophys 306:200, 1993
20. Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, Clauser KR, Wells JA: Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821, 1991
21. de Vos AM, Ultsch M, Kossiakoff AA: Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255:306, 1992
22. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA: Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677, 1992
23. Rui H, Lebrun J-J, Kirken RA, Kelly PA, Farrar WL: JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. Endocrinology 185:1299, 1994
24. Palacios R, Steinmetz M: IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41:727, 1985
25. Winkelmann JC, Penny LA, Deaven LL, Forget BG, Jenkins BB: The gene for the human erythropoietin receptor: Analysis of the coding sequence and assignment to chromosome 19p. Blood 76:24, 1990
26. Jones SS, D'Andrea AD, Haines LL, Wong GG: Human erythropoietin receptor: Cloning, expression, and biologic characterization. Blood 76:31, 1990
27. Komatsu N, Yamamoto M, Fujita H, Miwa A, Hatake K, Endo T, Okano H, Katsube T, Fukumaki Y, Sassa S, Miura Y: Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Blood 82:456, 1993
28. Broudy VC, Lin N, Egrie J, De-Haen C, Weiss T, Papayannopoulou T, Adamson JW: Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide. Proc Natl Acad Sci USA 85:6513, 1988
29. Iscove NN, Sieber F, Winterhalter KH: Erythroid colony formation in cultures of mouse and human bone marrow: Analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J Cell Physiol 83:309, 1974
30. Pouting ILO, Izumi R, Covey T: Maintenance of long-term hematopoiesis using a novel non-serum bone marrow culture system. Exp Hematol 22:810, 1994
31. Johnsson U, Malmqvist M: Real time biospecific interaction analysis - The integration of surface plasmon resonance detection, general biospecific interface chemistry and microfluidics into one analytical system. Adv Biosens 2:291, 1992
32. Johnsson B, Lofas S, Lindquist G: Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem 198:268, 1991
33. Karlsson R, Michaelsson A, Mattsson L: Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J Immunol Methods 145:229, 1991
34. Nicolis S, Ottolenghi S, Papayannopoulou T, Baiocchi M, Migliaccio G, Adamson J, Migliaccio AR: Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7. Exp Hematol 21:665, 1993
35. Perelson AS: Some mathematical models of receptor clustering by multivalent ligands, in Perelson AS, DeLisi C, Wiegel FW (eds): Cell Surface Dynamics: Concepts and Models. New York, NY, Marcel Dekker, 1984, p 223
36. Hondo MM, Damholt AB, Cunningham BC, Wells JA, De Meyts P, Shymko RM: Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes. Endocrinology 134:2937, 1994
37. Elberg G, Kelly PA, Djiane J, Binder L, Gertler A: Mitogenic and binding properties of monoclonal antibodies to the prolactin receptor in Nb2 rat lymphoma cells. J Biol Chem 265:14770, 1990
38. Matthews DJ, Topping RS, Cass RT, Giebel LB: A sequential dimerization mechanism for erythropoietin receptor activation. Proc Natl Acad Sci USA 93:9471, 1996
39. D'Andrea AD, Rup BJ, Fisher MJ, Jones S: Anti-erythropoietin receptor (EPO-R) monoclonal antibodies inhibit erythropoietin binding and neutralize bioactivity. Blood 82:46, 1993
40. Bailey SC, Feldman L, Romanowski RR, Davis KL, Sytkowski AJ: Antipeptide antibodies as probes of the recombinant and endogenous murine erythropoietin receptors. Exp Hematol 21:1535, 1993
41. Fisher MJ, Prchal JF, Prchal JT, D'Andrea AD: Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera. Blood 84:1982, 1994
42. Witthuhn BA, Quelle FW, Silvennionen O, Yi T, Tang B, Miura O, Ihle JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227, 1993
43. Yarden Y, Schlessinger J: Self-phosphorylation of epidermal growth factor receptor: Evidence for a model of intermolecular allosteric activation. Biochemistry 26:1434, 1987
44. Kelly JD, Haldeman BA, Grant FJ, Murray MJ, Seifert RA, Bowen-Pope DF, Cooper JA, Kazlauskas A: Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation. J Biol Chem 266:8987, 1991